期刊文献+

结直肠癌细胞增殖核抗原及生长抑制因子4表达的关系及预后因素 被引量:4

Relationship between Ki-67 and ING4 expression and their prognostic significance in colorectal cancer
下载PDF
导出
摘要 目的探讨细胞增殖核抗原(Ki-67)和生长抑制因子4(ING4)在结直肠癌发病机制中的作用及其对患者预后的影响。方法应用免疫组织化学法检测71例结直肠癌组织和30例癌旁正常组织中Ki-67、ING4的表达情况,分析其表达与临床病理特征及预后的关系。结果 Ki-67在癌组织中阳性表达率(85.9%)高于癌旁组织(6.7%)(P<0.05),ING4在癌组织中阳性表达率(56.3%)低于癌旁组织(90%)(P<0.05)。Ki-67表达与肿瘤浸润深度、有无淋巴结转移、淋巴结转移数目、TNM分期有关(P<0.05),ING4表达与分化程度、有无淋巴结转移、淋巴结转移数目、TNM有关(P<0.05)。Ki-67、ING4在结直肠癌组织中表达呈负相关性(r=-0.428,P<0.05)。Ki-67高表达组和低表达组术后5年生存率分别为63.9%、85.5%,差异有统计学意义(P<0.05);ING4阳性组和阴性组术后5年生存率分别为97.4%、45.2%,差异有统计学意义(P<0.05)。Cox多因素分析结果显示,TNM分期、ING4表达情况均为影响患者预后的独立因素。结论 Ki-67、ING4可能参与直肠癌的发生和发展,ING4是影响结直肠癌患者预后的独立危险因素。 Objective To investigate the expression of Ki-67 and ING4 and their influence on survival in patients with coloreetal cancer. Methods The expressions of Ki-67 and ING4 proteins were detected by immunohistochemistry in coloreetal cancer tissues from 71 cases of colorectal cancer and normal colorectal tissues from 30 corresponding para-cancerous normal tissues. The correlations between the expressions of Ki-67, ING4 and clinicopathological parameters and prognostic significance were also analyzed. Results The colorectal cancer tissues' s positive expression rates of Ki-67 was 85.9%, which was significantly higher in innormal tissue group (6. 7% ) (P 〈 0. 05 ), The colorectal cancer tissues' s positive expression rates of ING4 was 56.3% , which was significantly lower in innormal tissue group(90% )(P 〈0. 05 ). Ki-67 expressions in eolorectal cancer tissues were correlated with infiltration depth,lymph node metastasis, number of lymph node metastasis and TNM staging ( P 〈 0. 05 ). ING4 expressions in colorectal cancer tissues were correlated with histological grade, lymph node metastasis, number of lymph node metastasis and TNM staging( P 〈 0.05 ). Ki-67 was negatively correlated with ING4 ( r = - 0. 428 ,P 〈 0. 05 ). The 5-year survival rate in the Ki-67 positive group (63.9%) was lower compared with the Ki-67 negative group (85.5%) (P 〈0. 05). The 5-year survival rate in the ING4 positive group(97.4% ) was higher compared with the ING4 negative group (45.2%) (P 〈 0. 05 ). The multivariate analysis showed that TMN stage and ING4 are independent prognostic factors in colorectal cancer. Conclusion Ki-67 and ING4 may be involved in the occurrence and development of colorectal cancer, and ING4 is independent factors affecting the prognosis in patient with colorectal cancer.
出处 《安徽医科大学学报》 CAS 北大核心 2018年第1期132-136,共5页 Acta Universitatis Medicinalis Anhui
基金 新疆生产建设兵团卫生科技计划
关键词 结直肠癌 细胞增殖核抗原 生长抑制因子4 预后 colorectal cancer Ki-67 ING4 prognosis
  • 相关文献

参考文献4

二级参考文献20

  • 1Qiu‐shiWang,MingLi,Lin‐youZhang,YanJin,Dan‐danTong,YangYu,JingBai,QiHuang,Fang‐LiLiu,AnLiu,Ki‐YoungLee,Song‐binFu.Down‐regulation of ING4 is associated with initiation and progression of lung cancer[J].Histopathology.2010(2)
  • 2XueLi Zhang,WeiYing Zhu,JiFa Zhang,ShouJun Huo,LianMing Zhou,Zhen Gu,Min Zhang.MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity[J].Biochemical and Biophysical Research Communications.2010(2)
  • 3Li, Xiaomei,Cai, Limin,Chen, Hui,Zhang, Qingyuan,Zhang, Shujun,Wang, Yanhua,Dong, Yanyan,Cheng, Hui,Qi, Jiping.Inhibitor of Growth 4 Induces Growth Suppression and Apoptosis in Glioma U87MG[J].Pathobiology.2009(4)
  • 4Jian Chen,Songji Zhao,Kunihiro Nakada,Yuji Kuge,Nagara Tamaki,Futoshi Okada,Jingxin Wang,Masanobu Shindo,Fumihiro Higashino,Kohji Takeda,Masahiro Asaka,Hiroyuki Katoh,Toshio Sugiyama,Masuo Hosokawa,Masanobu Kobayashi.Dominant-Negative Hypoxia-Inducible Factor-1α Reduces Tumorigenicity of Pancreatic Cancer Cells through the Suppression of Glucose Metabolism[J].The American Journal of Pathology.2003(4)
  • 5Vassiliki Zolota,Anna Batistatou,Athanassios C. Tsamandas,George Iliopoulos,Chrisoula D. Scopa,Dionysis S. Bonikos.??Immunohistochemical expression of TGF-β1, p21 WAF1, p53 , Ki67, and angiogenesis in gastric carcinomas(J)International Journal of Gastrointestinal Cancer . 2002 (2-3)
  • 6Carlos L. Arteaga,Stacy L. Moulder,F.Michael Yakes.??HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer(J)Seminars in Oncology . 2002 (3)
  • 7D. M. Schonk,H. J. H. Kuijpers,E. Drunen,C. H. Dalen,A. H. M. Geurts van Kessel,R. Verheijen,F. C. S. Ramaekers.??Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10(J)Human Genetics . 1989 (3)
  • 8Kavanagh Dara,Chambers Gillian,O’ Grady Liam,Barry Kevin,Waldron Ronan,Bennani Fadel,Eustace Paul,Tobbia Iqdam.Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?. BMC Cancer . 2009
  • 9Saleh HA,Jackson H,Banerjee M.Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia. Applied Immunohistochemistry . 2000
  • 10AC Wolff,ME Hammond,JN Schwartz,KL Hagerty,DC Allred,RJ Cote,M Dowsett,PL Fitzgibbons,WM Hanna,A Langer,LM McShane,S Paik,MD Pegram,EA Perez,MF Press,A Rhodes,C Sturgeon,SE Taube,R Tubbs,GH Vance,van de Vijver M,TM Wheeler,DF Hayes.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Archives of Pathology . 2007

共引文献1144

同被引文献37

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部